21，Calnan JS, Copenhagen HJ. Autotransplantation of keloid in man. Br J Surg, 1967, 54(5): 330.
32，Lorenze HP, Longaker MT, Perkocha LA, et al. Scarless wound repair: a human fetal skin model. Development, 1992, 114: 253.
44，Schor SL, Schor AM, Grey AM, et al. Foetal and cancer patients fibroblasts producted an autocrine migratiom stimulating factor not made by normal adult cells. J Cell Sci, 1988, 90(3): 391.
55，Russell SB, Trupin KM, Rodriguez Eaton S, et al. Reduced growth factor requirement of keloid derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA, 1988, 85(2): 587.
67，Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of connective tissue in keloid and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol, 1985, 84(5): 384.
78，Zhang K, Garner W, Cohen L, et al. Increased typesⅠ and Ⅲ collagen and transforming growth factor-beta 1 mRNA and protein hypertrophic burn scar. J Invest Dermatol, 1995, 104(5): 750.
89，Russell SB, Trupin JS, Kennedy RZ, et al. Glucocorticoid regulation of elastin synthesis in human fibroblasts: down-regulation in fibroblasts from normal dermis but not from keloids. J Invest Dermatol, 1995, 104(2): 241.
910，Varedi M, Tredget EE, Scott PG, et al. Alteration in cell morphology triggers transforming growth factor beta 1、collagenase and tissue inhibitor of metalloproteinase-Ⅰ expression in normal and hypertrophic scar fibroblast. J Invest Dermatol, 1995, 104(1): 118.
1011，Arakawa M, Hatamochi A, Mori Y, et al. Reduced collagenase gene expression in fibroblast from hypertrophic scar tissue. Br J Dermatol, 1996, 134(5): 863.
